Literature DB >> 31806579

Exendin-based glucagon-like peptide-1 receptor agonists and anaphylactic reactions: a pharmacovigilance analysis.

Richeek Pradhan1, François Montastruc2, Vanessa Rousseau2, Elisabetta Patorno3, Laurent Azoulay4.   

Abstract

Year:  2019        PMID： 31806579     DOI： 10.1016/S2213-8587(19)30382-1

Source DB:  PubMed          Journal:  Lancet Diabetes Endocrinol        ISSN： 2213-8587            Impact factor:   32.069


× No keyword cloud information.
  2 in total

1.  Hypoglycemia following the use of glucagon-like peptide-1 receptor agonists: a real-world analysis of post-marketing surveillance data.

Authors:  Zhe Zhao; Yan Tang; Yang Hu; Huijuan Zhu; Xiaoguang Chen; Bin Zhao
Journal:  Ann Transl Med       Date:  2021-09

Review 2.  GLP-1 Receptor Agonists and Coronary Arteries: From Mechanisms to Events.

Authors:  Aurélie Pahud de Mortanges; Eldem Sinaci; Dante Salvador; Lia Bally; Taulant Muka; Matthias Wilhelm; Arjola Bano
Journal:  Front Pharmacol       Date:  2022-03-08       Impact factor: 5.810
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.